SCHEMBL29596517

SCHEMBL29596517

C[Si](C)(C)C#Cc1cnc(N)nn1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22911964 1.00 HDAC1 (0.31) HDAC1HDAC6
SCHEMBL22911955 0.76 — —
SCHEMBL23627444 0.73 NOS3 (0.31) —
SCHEMBL20929102 0.73 GRM5 (0.30) —
SCHEMBL1349094 0.72 HSP90AA1 (0.35) —
SCHEMBL22911966 0.71 — —
SCHEMBL651271 0.69 NOS3 (0.31) —
SCHEMBL1137069 0.68 ADRA2A (0.37) —
SCHEMBL29350657 0.68 ADRA2A (0.37) —
SCHEMBL5290860 0.67 GRM4 (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3999498-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES Kinnate Biopharma Inc. (US) 2022-05-25 — — EP disclosed
CN-114401955-A Inhibitors of cyclin dependent kinases 金耐特生物制药公司 2022-04-26 — — CN disclosed
Send feedback